Skip to Main Content
An official website of the United States government
Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, January 3rd from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime..

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
2561-2580 of 2618
Name Principal Investigator Institution Study Date Approved Project ID
Racial Factors and Compliance with PLCO Procedures Joel Weissfeld University of Pittsburgh PLCO Jul 1, 2006 2006-0278
HSQ Validation Study Lisa Gren University of Utah PLCO Jul 1, 2006 2006-0310
Effects of Distance and Screening Type on Compliance Sheryl Ogden University of Colorado Health Sciences Center PLCO Jul 1, 2006 2006-0311
Recruitment of Minorities in the PLCO Trial Paul Pinsky NCI, DCP, EDRG PLCO Jul 1, 2006 2006-0312
Diagnostic Procedures Following Lung Cancer Screens with non-Cancer Abnormalities Lois Lamerato Henry Ford Health System PLCO Jul 1, 2006 2006-0315
Questionnaire Risk Factors and Multiple Disease Outcomes in PLCO Wen-Yi Huang NCI, DCEG, OEEB PLCO Jul 1, 2006 2006-0321
Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma Ola Landgren NCI, DCEG, GEB PLCO Jun 7, 2006 2005-0017
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0015
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021
Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0024
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort Catherine McCarty Marshfield Clinic Research Foundation PLCO Apr 21, 2006 2005-0027
Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer Timothy Church University of Minnesota PLCO Apr 21, 2006 2005-0029
Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial Timothy Church University of Minnesota PLCO Mar 31, 2006 2006-0307
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-1 CT Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00324
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-0 CXR Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00391
Cell Cycle Variants and Metastatic Prostate Cancer Risk Adam Kibel Washington University PLCO Aug 17, 2005 2005-0001
Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma Nathaniel Rothman - PLCO Aug 17, 2005 2005-0002